$OFIX
Orthofix Medical Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023019721 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $187.0M $175.2M $106.4M
YoY Change 58.39% 64.64% 0.78%
Cost Of Revenue $67.47M $64.88M $28.32M
YoY Change 113.5% 129.09% 9.28%
Gross Profit $119.6M $110.3M $78.10M
YoY Change 38.26% 41.27% -1.98%
Gross Profit Margin 63.93% 62.97% 73.39%
Selling, General & Admin $133.4M $142.6M $73.47M
YoY Change 76.18% 94.11% 9.28%
% of Gross Profit 111.61% 129.25% 94.07%
Research & Development $19.42M $23.31M $11.21M
YoY Change 52.25% 107.88% 2.89%
% of Gross Profit 16.25% 21.12% 14.36%
Depreciation & Amortization $13.33M $12.67M $7.516M
YoY Change 104.65% 68.57% 1.57%
% of Gross Profit 11.15% 11.48% 9.62%
Operating Expenses $152.9M $165.9M $84.68M
YoY Change 72.73% 95.93% 8.39%
Operating Profit -$36.63M -$59.71M -$3.078M
YoY Change -651.6% 1840.03% 5.56%
Interest Expense -$1.266M -$1.289M -$375.0K
YoY Change 211.06% 243.73% -6.25%
% of Operating Profit
Other Income/Expense, Net -$20.00K $676.0K -$936.0K
YoY Change -99.37% -172.22% -65.2%
Pretax Income -$37.92M -$60.33M -$4.389M
YoY Change -1346.48% 1274.5% -27.13%
Income Tax $1.508M $611.0K $71.00K
% Of Pretax Income
Net Earnings -$39.43M -$60.94M -$4.460M
YoY Change -1684.01% 1266.32% -23.31%
Net Earnings / Revenue -21.08% -34.78% -4.19%
Basic Earnings Per Share -$1.07 -$1.71 -$0.22
Diluted Earnings Per Share -$1.07 -$1.71 -$0.22
COMMON SHARES
Basic Shares Outstanding 36.54M 36.46M 19.90M
Diluted Shares Outstanding 36.76K 35.73K 19.90M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.61M $49.97M $71.92M
YoY Change -36.83% -30.52% -23.98%
Cash & Equivalents $37.61M $49.97M $71.92M
Short-Term Investments
Other Short-Term Assets $26.95M $24.83M $21.89M
YoY Change 25.83% 13.43% 46.9%
Inventory $222.5M $221.9M $88.83M
Prepaid Expenses
Receivables $112.3M $113.3M $72.47M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $399.3M $410.0M $255.1M
YoY Change 56.49% 60.74% -3.15%
LONG-TERM ASSETS
Property, Plant & Equipment $140.6M $136.8M $58.51M
YoY Change 139.59% 133.82% -12.67%
Goodwill $191.7M $202.7M $71.32M
YoY Change 168.84% 184.24%
Intangibles $126.0M $122.1M $50.17M
YoY Change 148.84% 143.43%
Long-Term Investments
YoY Change
Other Assets $43.63M $45.44M $24.96M
YoY Change 78.93% 82.05% -38.52%
Total Long-Term Assets $501.9M $507.1M $206.9M
YoY Change 143.11% 145.1% -17.41%
TOTAL ASSETS
Total Short-Term Assets $399.3M $410.0M $255.1M
Total Long-Term Assets $501.9M $507.1M $206.9M
Total Assets $901.3M $917.1M $462.0M
YoY Change 95.23% 98.52% -10.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.35M $45.88M $27.45M
YoY Change 58.87% 67.13% 30.09%
Accrued Expenses $3.159M $3.241M $1.461M
YoY Change 129.75% 121.83% -30.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $678.0K $664.0K $610.0K
YoY Change 8.65% 8.85% -75.6%
Total Short-Term Liabilities $141.8M $137.6M $88.21M
YoY Change 74.86% 55.96% -10.99%
LONG-TERM LIABILITIES
Long-Term Debt $51.00M $45.00M $19.73M
YoY Change 160.59% 128.08% -2.81%
Other Long-Term Liabilities $49.60M $51.34M $18.48M
YoY Change 160.5% 177.85% -53.46%
Total Long-Term Liabilities $100.6M $96.34M $18.48M
YoY Change 428.33% 421.38% -69.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $141.8M $137.6M $88.21M
Total Long-Term Liabilities $100.6M $96.34M $18.48M
Total Liabilities $261.3M $253.0M $126.4M
YoY Change 118.28% 100.11% -20.54%
SHAREHOLDERS EQUITY
Retained Earnings -$99.11M -$59.69M $16.54M
YoY Change -620.85% -460.86%
Common Stock $739.2M $724.8M $320.2M
YoY Change 126.93% 126.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $640.0M $664.2M $335.6M
YoY Change
Total Liabilities & Shareholders Equity $901.3M $917.1M $462.0M
YoY Change 95.23% 98.52% -10.1%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$39.43M -$60.94M -$4.460M
YoY Change -1684.01% 1266.32% -23.31%
Depreciation, Depletion And Amortization $13.33M $12.67M $7.516M
YoY Change 104.65% 68.57% 1.57%
Cash From Operating Activities -$5.516M -$34.02M -$7.709M
YoY Change 12.27% 341.3% -415.81%
INVESTING ACTIVITIES
Capital Expenditures $12.82M $11.47M $5.329M
YoY Change -312.38% 115.27% 22.08%
Acquisitions
YoY Change
Other Investing Activities $0.00 $500.0K
YoY Change -100.0%
Cash From Investing Activities -$12.82M $17.08M -$5.667M
YoY Change 71.06% -401.46% 18.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.808M 15.98M -2.233M
YoY Change 538.94% -815.76% -301.17%
NET CHANGE
Cash From Operating Activities -5.516M -34.02M -7.709M
Cash From Investing Activities -12.82M 17.08M -5.667M
Cash From Financing Activities 5.808M 15.98M -2.233M
Net Change In Cash -12.53M -732.0K -15.93M
YoY Change 8.95% -95.4% 803.06%
FREE CASH FLOW
Cash From Operating Activities -$5.516M -$34.02M -$7.709M
Capital Expenditures $12.82M $11.47M $5.329M
Free Cash Flow -$18.33M -$45.49M -$13.04M
YoY Change -1732.68% 248.92% 577.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000884624
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
0-19961
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ORTHOFIX MEDICAL INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1340767
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3451 Plano Parkway
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Lewisville
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75056
CY2023Q1 dei City Area Code
CityAreaCode
214
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
937-2000
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36544297
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.10 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
OFIX
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49968000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50700000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6691000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6419000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113313000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82857000
CY2023Q1 us-gaap Inventory Net
InventoryNet
221933000
CY2022Q4 us-gaap Inventory Net
InventoryNet
100150000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24827000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22283000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
410041000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
255990000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
136818000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58229000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
122129000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
47388000
CY2023Q1 us-gaap Goodwill
Goodwill
202711000
CY2022Q4 us-gaap Goodwill
Goodwill
71317000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45437000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25705000
CY2023Q1 us-gaap Assets
Assets
917136000
CY2022Q4 us-gaap Assets
Assets
458629000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
45875000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27598000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
664000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
652000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
91029000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
55374000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
137568000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83624000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
45000000
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19068000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19239000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
51341000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18906000
CY2023Q1 us-gaap Liabilities
Liabilities
252977000
CY2022Q4 us-gaap Liabilities
Liabilities
121769000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36463000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36463000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20162000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20162000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3647000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2016000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
721145000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
334969000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59687000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1251000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-946000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1376000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
664159000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
336860000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
917136000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
458629000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175204000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106418000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64875000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28318000
CY2023Q1 us-gaap Gross Profit
GrossProfit
110329000
CY2022Q1 us-gaap Gross Profit
GrossProfit
78100000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
93791000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
54137000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48811000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19328000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23307000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11212000
CY2023Q1 ofix Acquisition Related Amortization And Remeasurement
AcquisitionRelatedAmortizationAndRemeasurement
4134000
CY2022Q1 ofix Acquisition Related Amortization And Remeasurement
AcquisitionRelatedAmortizationAndRemeasurement
-3499000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-59714000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3078000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1289000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-375000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
676000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-936000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60327000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4389000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
611000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
71000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-60938000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4460000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.71
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.71
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35734
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19898
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35734
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19898
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-63000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-674000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
493000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-488000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
430000
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-1162000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
430000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1162000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60508000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5622000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
336860000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-60938000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
430000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13020000
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
376745000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-1958000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
664159000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
336934000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4460000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1162000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4332000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-69000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
335575000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-60938000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4460000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12670000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7516000
CY2023Q1 ofix Inventory Reserve Expenses
InventoryReserveExpenses
7412000
CY2022Q1 ofix Inventory Reserve Expenses
InventoryReserveExpenses
2332000
CY2023Q1 ofix Amortization Of Inventory Fair Value Step Up
AmortizationOfInventoryFairValueStepUp
11636000
CY2023Q1 ofix Amortization Of Lease Assets Debt Costs And Other Assets
AmortizationOfLeaseAssetsDebtCostsAndOtherAssets
1696000
CY2022Q1 ofix Amortization Of Lease Assets Debt Costs And Other Assets
AmortizationOfLeaseAssetsDebtCostsAndOtherAssets
798000
CY2023Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
208000
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
600000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
379000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13020000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4332000
CY2023Q1 ofix Change In Valuation Of Investment Securities
ChangeInValuationOfInvestmentSecurities
207000
CY2022Q1 ofix Change In Valuation Of Investment Securities
ChangeInValuationOfInvestmentSecurities
9000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5500000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
383000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-528000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4792000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5392000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16781000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8543000
CY2023Q1 ofix Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-2225000
CY2022Q1 ofix Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
1891000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3560000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1387000
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-5842000
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-6993000
CY2022Q1 ofix Cares Act Of2020 Aid Amount
CARESActOf2020AidAmount
-3395000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
347000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-233000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34020000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7709000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11472000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5329000
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
363000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
338000
CY2023Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
29419000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
500000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17084000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5667000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1958000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
69000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
160000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2141000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
45000000
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
26899000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-23000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15983000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2233000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-321000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-732000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15930000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50700000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
87847000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49968000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71917000
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
2000000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2200000
CY2023Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
0.4163
CY2023Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
175200000
CY2022Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
157100000
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-45200000
CY2022Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-42600000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
16900000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6691000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5389000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 ofix Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
3204000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
23143000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17035000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
58472000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19243000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
140318000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
63872000
CY2023Q1 us-gaap Inventory Net
InventoryNet
221933000
CY2022Q4 us-gaap Inventory Net
InventoryNet
100150000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21280000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6788000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
17106000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
17360000
CY2023Q1 ofix Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
38386000
CY2022Q4 ofix Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
24148000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3241000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1638000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
664000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
652000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18525000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5376000
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19068000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19239000
CY2023Q1 ofix Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
41498000
CY2022Q4 ofix Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
26905000
CY2022Q1 ofix Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
7109000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1289000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1674000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1068000
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
214000
CY2022Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
222000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
160000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2141000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15316000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4470000
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
26900000
CY2023Q1 ofix Prepayment Premium
PrepaymentPremium
600000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-375000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12670000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7516000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13020000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4332000
CY2023Q1 ofix Estimated Sales And Marketing Expense Benefit
EstimatedSalesAndMarketingExpenseBenefit
300000
CY2022Q1 ofix Estimated Sales And Marketing Expense Benefit
EstimatedSalesAndMarketingExpenseBenefit
300000
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
6300000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175204000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106418000
CY2023Q1 ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
0.646
CY2023Q1 ofix Revenue From Product Sales
RevenueFromProductSales
162248000
CY2022Q1 ofix Revenue From Product Sales
RevenueFromProductSales
92608000
CY2023Q1 ofix Marketing Service Fees
MarketingServiceFees
12956000
CY2022Q1 ofix Marketing Service Fees
MarketingServiceFees
13810000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175204000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106418000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6419000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4944000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
137000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
208000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
600000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
126000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
104000
CY2023Q1 ofix Effect Of Changes In Foreign Exchange Rates
EffectOfChangesInForeignExchangeRates
-53000
CY2022Q1 ofix Effect Of Changes In Foreign Exchange Rates
EffectOfChangesInForeignExchangeRates
51000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-583000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1242000
CY2023Q1 us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
20740000
CY2023Q1 ofix Strategic Investments
StrategicInvestments
661000
CY2022Q1 ofix Strategic Investments
StrategicInvestments
970000
CY2023Q1 ofix Acquisition Related Fair Value Adjustments
AcquisitionRelatedFairValueAdjustments
11636000
CY2022Q1 ofix Acquisition Related Fair Value Adjustments
AcquisitionRelatedFairValueAdjustments
-5500000
CY2023Q1 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
469000
CY2022Q1 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
193000
CY2023Q1 ofix Medical Device Regulation
MedicalDeviceRegulation
3629000
CY2022Q1 ofix Medical Device Regulation
MedicalDeviceRegulation
1952000
CY2022Q1 ofix Business Interruption Covid19
BusinessInterruptionCovid19
343000
CY2022Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
75000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60327000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4389000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175204000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106418000
CY2023Q1 ofix Acquisition Related Amortization Expense
AcquisitionRelatedAmortizationExpense
4134000
CY2022Q1 ofix Acquisition Related Amortization Expense
AcquisitionRelatedAmortizationExpense
2001000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5500000
CY2023Q1 ofix Business Combination Acquisition Related Amortization And Remeasurement
BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement
4134000
CY2022Q1 ofix Business Combination Acquisition Related Amortization And Remeasurement
BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement
-3499000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13020000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4332000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13020000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4332000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.010
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.016
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35734
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19898
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35734
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19898

Files In Submission

Name View Source Status
0000950170-23-019721-index-headers.html Edgar Link pending
0000950170-23-019721-index.html Edgar Link pending
0000950170-23-019721.txt Edgar Link pending
0000950170-23-019721-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img221709767_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
ofix-20230331.htm Edgar Link pending
ofix-20230331.xsd Edgar Link pending
ofix-ex31_1.htm Edgar Link pending
ofix-ex31_2.htm Edgar Link pending
ofix-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
ofix-20230331_lab.xml Edgar Link unprocessable
ofix-20230331_cal.xml Edgar Link unprocessable
ofix-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ofix-20230331_pre.xml Edgar Link unprocessable
ofix-20230331_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending